Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, Beijing Delian Yuntong Investment Management Company, Insight Capital (Taicang), Haihong Investment, Guoqian Venture Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Yaoshi Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Yaoshi Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Yaoshi Medical Technology
Manufacturer of ophthalmic diagnostic equipment designed to integrate optical technology and AI for clinical applications. The company offers ultra-wide-angle confocal scanning laser ophthalmoscopes, AI-assisted diagnostic platforms, retinal imaging systems, optical modules and data processing units, thereby enhancing early detection of fundus diseases and supporting precision diagnostics in ophthalmology.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2020
- Website
- yesight.com/
- Ownership
- Privately Held (backing)
Yaoshi Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Yaoshi Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Yaoshi Medical Technology in its N-PORT filings yet. We sweep new filings monthly.